Search - tctmd.com

Displaying 1 - 20 of 29

Sort: Relevancy | Date

News Daily News

肾病患者中心血管干预的数据有限，导致医生难以照料这一易感人群。

Michael O'Riordan

December 03, 2015

News Daily News

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Michael O'Riordan

December 03, 2015

News Daily News

Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal

Michael O'Riordan

December 03, 2015

Presentation TCT 2014

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

Presenter: Michael Joner, Horst Sievert, Steven L. Almany, John A. Ormiston

September 16, 2014

Presentation TCT 2014

TCT 404: First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi

September 14, 2014

Presentation TCT 2014

Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update

Presenter: Michael R. Jaff, Horst Sievert, Michael J. Rinaldi, John A. Ormiston

September 14, 2014

Presentation TCT 2014

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Antonios Karanasos

September 14, 2014

Presentation TCT 2014

Updates and Status of the Cordis Renlane Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Felix Mahfoud

September 14, 2014

Presentation TCT 2014

Updates and Status of the ReCor Paradise Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Thomas Zeller

September 14, 2014

Presentation TCT 2014

Updates and Status of the St. Jude EnligHTN Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Updates and Status of the Boston Scientific Vessix Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Ajay J. Kirtane

September 14, 2014

Presentation TCT 2014

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, Michael Boehm

September 14, 2014

Presentation TCT 2014

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray, John Flack

September 14, 2014

Presentation TCT 2014

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Presenter: Deepak L. Bhatt, Michael A. Weber, William A. Gray

September 14, 2014

Presentation TCT 2014

Current Status of Advanced Hypertension Treatment in the United States

Presenter: Ajay J. Kirtane, Felix Mahfoud, John A. Ormiston, Michael A. Weber

September 13, 2014

Presentation TCT 2014

Renal Nerve Microanatomy - The Foundation for RDN Technologies

Presenter: Juan F. Granada, Paul A. Sobotka, Farrell O. Mendelsohn, Michael Joner

September 13, 2014

News Conference News ESC 2014

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Todd Neale

September 01, 2014

News Conference News ACC 2014

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

Yael L. Maxwell

March 30, 2014

News Daily News

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

Yael L. Maxwell

December 30, 2013

News Daily News

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Yael L. Maxwell

December 30, 2013

Advertisement

肾病患者中心血管干预的数据有限，导致医生难以照料这一易感人群。

More Than Half of CVD Studies Exclude Patients With Kidney Disease

Más de la Mitad de los Estudios sobre ECV Excluyen a Pacientes con Enfermedad Renal

Noninvasive Renal Denervation Using Externally Delivered Focused Ultrasound: Early Experience Using Doppler-Based Imaging Tracking and Targeting for Treatment

TCT 404: First Clinical Experience with Neurotropic Agents for Treatment of Sympathetic Hypertension

Extravascular Focused Ultrasound for Renal Denervation: Kona Medical Update

TCT 406: Renal Artery Trauma Induced by Four Different Renal Denervation Systems: A Multimodality Intraarterial Imaging Study

Updates and Status of the Cordis Renlane Program

Updates and Status of the ReCor Paradise Program

Updates and Status of the St. Jude EnligHTN Program

Updates and Status of the Boston Scientific Vessix Program

From SYMPLICITY HTN-1 to the Global SYMPLICITY Registry and Beyond: Updates from and Status of the SYMPLICITY Clinical Trial Program

TCT 405: SYMPLICITY HTN-3: Outcomes in the African-American and NonAfrican American Populations

First Deep Dive into SYMPLICITY HTN-3: Primary Results and Updated Analyses

Current Status of Advanced Hypertension Treatment in the United States

Renal Nerve Microanatomy - The Foundation for RDN Technologies

SYMPLICITY HTN-3: Renal Denervation Still Safe, Not Effective at 1 Year

Global SYMPLICITY Registry Still Shows Positive Results for Renal Denervation

RE-LY: Dabigatran es Seguro y Eficaz en Todos los Rangos de Función Renal

RE-LY: Dabigatran Safe, Effective Across Range of Renal Function

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content